Bausch & Lomb BLCO
NYSE BLCO
$17.56 -0.23 (-1.29%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch & Lomb (BLCO) Non-Current Assets (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Non-Current Assets came in at $10.9 billion in Q2 2026, little changed on a YoY basis from $11.0 billion in Q2 2025, and down 0.61% quarter-over-quarter from $11.0 billion in Q1 2026.

Analysis

Bausch & Lomb (BLCO) Non-Current Assets (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has reported Non-Current Assets for 6 consecutive years, with $10.9 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets changed 0.45% year-over-year to $10.9 billion; the trailing twelve-month figure through Jun 2026 stood at $44.0 billion (up 2.03% YoY), and the FY2025 full-year result was $11.0 billion, up 3.41% from the prior year.
  • Non-Current Assets fell to $10.9 billion in Q2 2026 per BLCO's latest filing, from $11.0 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $11.0 billion in Q4 2025 and bottomed at $8.8 billion in Q3 2022.
  • Historically, Non-Current Assets has averaged $10.2 billion across 5 years, with a median of $10.6 billion in 2023.
  • The widest YoY moves for Non-Current Assets: up 20.0% in 2023, down 2.21% in 2023.
  • Over 5 years, Non-Current Assets stood at $9.0 billion in 2022, then gained by 18.8% to $10.7 billion in 2023, then declined by 0.18% to $10.7 billion in 2024, then gained by 3.41% to $11.0 billion in 2025, then fell by 0.98% to $10.9 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $10.9 billion, $11.0 billion, and $11.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 11.33 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 68.92 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 7.05 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 2.37 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 8.29 Bn
10 Bausch & Lomb 6.28 Bn 5.90 Bn 867.00 Mn 10.94 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.94 Bn
Mar 31, 2026 11.00 Bn
Dec 31, 2025 11.05 Bn
Sep 30, 2025 10.98 Bn
Jun 30, 2025 10.99 Bn
Mar 31, 2025 10.73 Bn
Dec 31, 2024 10.68 Bn
Sep 30, 2024 10.69 Bn
Jun 30, 2024 10.48 Bn
Mar 31, 2024 10.55 Bn
Dec 31, 2023 10.70 Bn
Sep 30, 2023 10.60 Bn
Jun 30, 2023 9.00 Bn
Mar 31, 2023 8.99 Bn
Dec 31, 2022 9.01 Bn
Sep 30, 2022 8.84 Bn
Jun 30, 2022 9.00 Bn
Mar 31, 2022 9.19 Bn
Dec 31, 2021 9.19 Bn